IMS Health Top 20 pharmaceutical companies 2009 Posted 23/04/2010

The 2009 list of the top 20 pharmaceutical companies, ranked by IMS Health according to global prescription drug sales for the 12 months up to September 2009, shows that Teva, Novo Nordisk and Boehringer Ingelheim scored better in percent change than Big Pharma in those months.

The data below does not take into account the large acquisitions by Pfizer and Merck, of Wyeth and Schering-Plough respectively, which were completed after September 2009.

Company Sales

(billion US$)

% change

1. Pfizer

41.7

(0.8)

2. Novartis

36.7

7.0

3. Sanofi-aventis

35.1

3.3

4. GlaxoSmithKline

34.3

(3.4)

5. AstraZeneca

33.2

7.8

6. Roche

31.3

8.6

7. Johnson & Johnson

26.9

(6.6)

8. Merck & Co

25.0

(4.1)

9. Eli Lilly

19.6

8.3

10. Abbott

19.4

5.5

11. Teva

15.7

12.3

12. Bayer

15.4

3.9

13. Wyeth

14.8

(2.3)

14. Amgen

14.8

(3.1)

15. Boehringer Ingelheim

14.6

10.4

16. Takeda

14.4

2.1

17. Bristol-Myers

14.2

5.8

18. Schering-Plough

13.1

4..3

19. Daiichi Sankyo

8.5

3.1

20. Novo Nordisk

8.2

11.6

References:

IMS Health

FACTBOX-The 20 largest pharmaceutical companies. Reuters. 2010 March 26.

Comments (0)